内部人交易记录
其他基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Jamil Khurram. Officer active across 1 company, notably Galectin Therapeutics INC. Aggregated, 17 filings have been logged. Breakdown: 0 buy · 8 sells. Total volume traded: €205k. Activity tracked since 23 December 2024. The latest transaction was disclosed on 14 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Jamil Khurram
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
16,250 股@ US$3.04Common StockSEC:0001133416-26-000063:0
16,250 股@ US$5.1252Common StockSEC:0001133416-26-000063:1
2,533 股Common StockSEC:0001133416-26-000059:2
2,533 股Common StockSEC:0001133416-26-000059:3
47,467 股Common StockSEC:0001133416-26-000059:4
47,467 股Common StockSEC:0001133416-26-000059:5
2,037 股Common StockSEC:0001133416-26-000059:0
2,037 股Common StockSEC:0001133416-26-000059:1
7,557 股Common StockSEC:0001133416-26-000057:0
7,557 股Common StockSEC:0001133416-26-000057:1
568 股@ US$3.10040.0011% mcap71.6% 占其流量Common StockSEC:0001133416-26-000055:1
568 股@ US$1.230.0004% mcap28.4% 占其流量Common StockSEC:0001133416-26-000055:0
60,000 股0Common StockSEC:0001133416-26-000004:0
8,125 股@ US$1.231.9% 占其流量Common StockSEC:0001133416-26-000002:0
4,479 股@ US$7.0420.3% 占其流量Common StockSEC:0001133416-25-000069:0
21,867 股@ US$5.4798.0% 占其流量Common StockSEC:0001133416-25-000054:0
40,000 股0Common StockSEC:0001133416-24-000072:0
About Jamil Khurram
Jamil Khurram is Chief Medical Officer at Galectin Therapeutics INC, listed on XNAS. He has 11 filings in total, and across the 11 sampled filings between 2024-12-26 and 2026-06-30, the recorded transactions are sales for EUR 1513, with the transaction nature mainly shown as option exercise.